Cargando…
The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study
BACKGROUND: Recently, side effects from Dopamine Receptor Agonist Drugs (DAs) in treating pituitary prolactinoma have raised widespread concern. This study explores the incidence and influencing factors of DAs-related side effects in Chinese prolactinoma patients. METHODS: A cross-sectional study wa...
Autores principales: | Ke, Xiaoan, Wang, Linjie, Chen, Meiping, Liu, Shanshan, Yu, Na, Duan, Lian, Gong, Fengying, Zhu, Huijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004168/ https://www.ncbi.nlm.nih.gov/pubmed/35410236 http://dx.doi.org/10.1186/s12902-022-01009-3 |
Ejemplares similares
-
The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019) -
Experience with Dopamine Agonists in the Treatment of Prolactinomas
por: Barabash, Nadiya Ye., et al.
Publicado: (2022) -
Predictors of dopamine agonist resistance in prolactinoma patients
por: Vermeulen, Elle, et al.
Publicado: (2020) -
Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
por: De Sousa, Sunita M C
Publicado: (2022) -
The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review
por: Chen, Meiping, et al.
Publicado: (2021)